| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/13/2011 | WO2011004361A2 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | WO2011004264A1 Methods and compositions for use in cellular therapies |
| 01/13/2011 | WO2011004201A1 Preserved compositions of activated nk cells and methods of using the same |
| 01/13/2011 | WO2011003988A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/13/2011 | WO2011003925A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | WO2011003153A1 Method of increasing the expression yield of vitamin k-dependent proteins |
| 01/13/2011 | WO2010130305A8 Automated separation of tissue layers |
| 01/13/2011 | WO2010105257A3 Generation of mouse induced pluripotent stem cells bytransient expression of a single non- viral polycistronic vector |
| 01/13/2011 | WO2010099169A3 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1 |
| 01/13/2011 | WO2010096693A3 Methods and materials for generating t cells |
| 01/13/2011 | WO2010096496A3 Methods of neural conversion of human embryonic stem cells |
| 01/13/2011 | US20110010807 Starch branching enzyme |
| 01/13/2011 | US20110010806 Method of directing the evolution of an organism |
| 01/13/2011 | US20110010805 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 01/13/2011 | US20110010804 Genes that increase plant oil and method for using the same |
| 01/13/2011 | US20110010803 Polypeptides, Such As Lipases, Capable Of Altering The Seed Storage Content In Transgenic Plants |
| 01/13/2011 | US20110010801 Maize cystatin promoter for pericarp preferred expression |
| 01/13/2011 | US20110010800 Plants with increased yield |
| 01/13/2011 | US20110010799 Floral Transition Genes in Maize and Uses Thereof |
| 01/13/2011 | US20110010798 Drought tolerant plants and related constructs and methods involving gene encoding ferrochelatases |
| 01/13/2011 | US20110010796 Water deficit-inducible promoters |
| 01/13/2011 | US20110010795 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/13/2011 | US20110010790 Plants with modified lignin content and methods for production thereof |
| 01/13/2011 | US20110010786 Transgenic animal expressing b cell antigen receptor |
| 01/13/2011 | US20110010785 Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 01/13/2011 | US20110010783 Method for reprogramming in vitro stem cells and somatic cells into germinal cells |
| 01/13/2011 | US20110010781 Method of Producing a Mouse Suitable for Engraftment, Differentiation and Proliferation of Heterologous Cells, Mouse Produced by This Method and Use of the Mouse |
| 01/13/2011 | US20110009603 Method and composition for crystallizing G protein-coupled receptors |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009488 Lipoxin A4 Protection for Cornea Endothelial Cells |
| 01/13/2011 | US20110009478 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009469 Compositions and methods of treating neoplasia |
| 01/13/2011 | US20110009466 Methods of increasing gene expression through rna protection |
| 01/13/2011 | US20110009430 Methods and compositions for treating pain |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009412 Macrophage migration inhibitory factor antagonists and methods of using same |
| 01/13/2011 | US20110009397 Triazone compounds that modulate hsp90 activity |
| 01/13/2011 | US20110009370 Method to enhance tissue regeneration |
| 01/13/2011 | US20110009360 Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis |
| 01/13/2011 | US20110009353 Targeting cdk4 and cdk6 in cancer therapy |
| 01/13/2011 | US20110009329 Method for treating neurodegenerative diseases |
| 01/13/2011 | US20110009328 Polypeptide Derivatives of Parathyroid Hormone (PTH) |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009311 Peptides and their utility in modulation of behavior of cells expressing alpha3 beta1 integrins |
| 01/13/2011 | US20110009280 Multi-chain eukaryotic display vectors and uses thereof |
| 01/13/2011 | US20110008893 Medium for mammalian somatic cells and additive therefor |
| 01/13/2011 | US20110008892 Methods of tissue generation and tissue engineered compositions |
| 01/13/2011 | US20110008891 Partial peptide of lacritin |
| 01/13/2011 | US20110008890 Self-Assembly of Peptide-Amphiphile Nanofibers Under Physiological Conditions |
| 01/13/2011 | US20110008889 Serpin drugs for treatment of hiv infection and method of use thereof |
| 01/13/2011 | US20110008888 Novel Genetic Approaches to Reduce or Inhibit Tumorgenicity of Human Embryonic Stem Cells and Derivatives Following Transplantation |
| 01/13/2011 | US20110008887 Epha4-positive human adult pancreatic endocrine progenitor cells |
| 01/13/2011 | US20110008886 Methods and materials for isolating isogenic islet cells |
| 01/13/2011 | US20110008885 Linear double-stranded rna molecule interfering with different target genes |
| 01/13/2011 | US20110008884 Pathology grossing tool, cassette, and board |
| 01/13/2011 | US20110008872 Immortalized Avian Cell Lines |
| 01/13/2011 | US20110008871 Production of Homogeneous Cell Line Highly Permissive To Porcine Circovirus Type 2 (PCV2) Infection |
| 01/13/2011 | US20110008844 Sialyltransferase and dna encoding the same |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008841 Polynucleotides encoding il-17 receptor a antigen binding proteins |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008839 Expression Vectors Comprising the MCMV IE2 Promoter |
| 01/13/2011 | US20110008837 Modifying glycoprotein production in plans |
| 01/13/2011 | US20110008836 Method for producing alpha-santalene |
| 01/13/2011 | US20110008835 System for the heterologous expression of a viral protein in a ciliate host cell |
| 01/13/2011 | US20110008834 Polynucleotides encoding antibodies directed against amyloid-beta peptide |
| 01/13/2011 | US20110008832 Methods for stably retaining foreign genes in cells |
| 01/13/2011 | US20110008819 Method of Differentiating Stem Cells |
| 01/13/2011 | US20110008786 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 01/13/2011 | US20110008770 Compositions and methods for reverse transcription of nucleic acid molecules |
| 01/13/2011 | US20110008769 Dopaminergic neuron progenitor cell marker 187a5 |
| 01/13/2011 | US20110008765 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 01/13/2011 | US20110008764 Human gonadal stem cells |
| 01/13/2011 | US20110008763 Materials and methods for flushing and cold/cryo preserving organs, tissues, and cells |
| 01/13/2011 | US20110008762 Methods for Preserving Organs and Tissues |
| 01/13/2011 | US20110008543 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/13/2011 | US20110008523 Genetic sequences having methyltransferase activity and uses therefor |
| 01/13/2011 | US20110008436 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008417 Immunomodulating compositions and uses therefor |
| 01/13/2011 | US20110008415 Novel lipophilic compositions and uses thereof |
| 01/13/2011 | US20110008397 Compartmental extract compositions for tissue engineering |
| 01/13/2011 | US20110008393 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 01/13/2011 | US20110008382 Compositions and methods using recombinant MHC molecules for the treatment of uveitis |
| 01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
| 01/13/2011 | US20110008364 Antibodies to tgf-beta |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008358 Human monoclonal antibodies that specifically bind igf-ii |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008355 Anti-flt3 antibodies |
| 01/13/2011 | US20110008354 Antibodies to apo-2 receptor polypeptides |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008348 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 01/13/2011 | US20110008347 Cancer-related protein kinases |
| 01/13/2011 | US20110008345 Antigen-binding constructs |
| 01/13/2011 | US20110008344 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008340 Anti-properdin antibodies |